| Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial S Saadati, A Sadeghi, A Mansour, Z Yari, H Poustchi, M Hedayati, ... BMC gastroenterology 19, 1-6, 2019 | 120 | 2019 |
| The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease S Saadati, B Hatami, Z Yari, MA Shahrbaf, S Eghtesad, A Mansour, ... European journal of clinical nutrition 73 (3), 441-449, 2019 | 88 | 2019 |
| Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: the global impacts of too much hygiene on AMR S Rezasoltani, A Yadegar, B Hatami, H Asadzadeh Aghdaei, MR Zali Frontiers in microbiology 11, 590683, 2020 | 87 | 2020 |
| The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: A systematic review and meta-analysis HV Kord, GM Tinsley, HO Santos, H Zand, A Nazary, S Fatahi, Z Mokhtari, ... Clinical nutrition 40 (4), 1811-1821, 2021 | 48 | 2021 |
| Outcome of acute kidney injury in critical care unit, based on AKI network SM Hashemian, H Jamaati, BF Bidgoli, FR Farrokhi, M Malekmohammad, ... Tanaffos 15 (2), 89, 2016 | 45 | 2016 |
| Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis AHM Alizadeh, M Abbasinazari, B Hatami, S Abdi, F Ahmadpour, S Dabir, ... European journal of gastroenterology & hepatology 29 (3), 349-354, 2017 | 38 | 2017 |
| Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies M Lotfinia, M Abdollahpour-Alitappeh, B Hatami, MR Zali, M Karimipoor Clinical and Experimental Medicine 19, 289-298, 2019 | 30 | 2019 |
| Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease S Saadati, A Hekmatdoost, B Hatami, A Mansour, Z Zahra, M Hedayati, ... Gastroenterology and hepatology from bed to bench 11 (Suppl 1), S8, 2018 | 26 | 2018 |
| Epinephrine in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary study B Hatami, SMH Kashfi, M Abbasinazari, E Nazemalhosseini Mojarad, ... Case Reports in Gastroenterology 12 (1), 125-136, 2018 | 23 | 2018 |
| Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial B Khodami, B Hatami, Z Yari, SM Alavian, A Sadeghi, HK Varkaneh, ... European Journal of Clinical Nutrition 76 (7), 987-994, 2022 | 22 | 2022 |
| Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis S Mazhari, A Gitiara, K Baghaei, B Hatami, RE Rad, A Asadirad, ... European Journal of Pharmacology 882, 173263, 2020 | 16 | 2020 |
| How patients with chronic liver diseases succeed to deal with COVID-19? S Rezasoltani, B Hatami, A Yadegar, H Asadzadeh Aghdaei, MR Zali Frontiers in Medicine 7, 398, 2020 | 15 | 2020 |
| Variants in two gene members of the TNF ligand superfamily and hepatitis C virus chronic disease SB Ghavami, SR Mohebbi, K Karimi, P Azimzadeh, A Sharifian, HM Yazdi, ... Gastroenterology and Hepatology from Bed to Bench 11 (Suppl 1), S66, 2018 | 15 | 2018 |
| Identifying predictors of varices grading in patients with cirrhosis using ensemble learning A Bayani, A Hosseini, F Asadi, B Hatami, K Kavousi, M Aria, MR Zali Clinical Chemistry and Laboratory Medicine (CCLM) 60 (12), 1938-1945, 2022 | 13 | 2022 |
| Glutamine powder-induced hepatotoxicity: it is time to understand the side effects of sports nutritional supplements B Hatami, A Saffaei, F Jamali, M Abbasinazari Gastroenterology and Hepatology from Bed to Bench 13 (1), 86, 2020 | 12 | 2020 |
| Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding H Abdollahi, MZ Azodi, B Hatami Gastroenterology and hepatology from bed to bench 10 (Suppl1), S146, 2017 | 12 | 2017 |
| Dietary and lifestyle inflammation scores are inversely associated with metabolic-associated fatty liver disease among Iranian adults: a nested case-control study E Taheri, RM Bostick, B Hatami, MA Pourhoseingholi, HA Aghdaei, ... The Journal of Nutrition 152 (2), 559-567, 2022 | 11 | 2022 |
| Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stage F Pashayee-Khamene, M Saber-Firoozi, B Hatami, B Rashidkhani, ... Gastroenterology and Hepatology from Bed to Bench 12 (3), 226, 2019 | 11 | 2019 |
| The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults E Taheri, MA Pourhoseingholi, A Moslem, AH Hassani, A Mousavi Jarrahi, ... Journal of Diabetes & Metabolic Disorders, 1-11, 2022 | 10 | 2022 |
| Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients B Hatami, S Ashtari, A Sharifian, HR Seraji, Y Hatami, MR Zali Gastroenterology and Hepatology From Bed to Bench 10 (Suppl1), S20, 2017 | 10 | 2017 |
